Company / Assets per Share
Serina Therapeutics, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.83
FY2025
5-year range
$0.08 / $8.31
FY2021-FY2025
Trend
-70.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $8.31 to $0.83 over the past 2 years.
Based on SEC 10-K filings.
0.83 in FY2025 with a 5-year CAGR of +51.3%.
Declined from $8.31 to $0.83 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +113.1%
- 5-Year CAGR
- +51.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 70.4% year-over-year.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.83 | -70.4% |
| FY2024 | $2.79 | -66.4% |
| FY2023 | $8.31 | +9629.9% |
| FY2022 | $0.09 | +2.1% |
| FY2021 | $0.08 | -19.7% |
| FY2020 | $0.10 | -67.0% |
| FY2018 | $0.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026